87492 Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, quantification

Name of the Procedure:

Infectious agent detection by nucleic acid (DNA or RNA); Chlamydia trachomatis, quantification

• Common names: Chlamydia PCR test, Chlamydia nucleic acid amplification test (NAAT)

Summary

This procedure involves taking a sample and testing it to determine the amount of Chlamydia trachomatis, a bacterial infection, present using nucleic acid (DNA or RNA) detection techniques.

Purpose

This test is performed to diagnose a Chlamydia trachomatis infection, assess the severity, and guide treatment decisions. The main goal is to determine the bacterial load to tailor treatment effectively.

Indications

• Symptoms such as abnormal genital discharge or pain during urination.
• Asymptomatic individuals during routine screenings.
• Sexual partners of individuals known to have Chlamydia.
• Pregnant women as part of prenatal screenings.

Preparation

• Patients may need to avoid urinating for up to two hours before providing a urine sample.
• No specific fasting or medication adjustments required.
• Inform your healthcare provider of any medications or supplements you're taking.

Procedure Description

1. A sample is collected using methods such as a swab of the affected area (e.g., cervix, urethra) or a urine sample.
2. The sample is placed in a sterile container and sent to a laboratory.
3. In the lab, nucleic acid amplification technologies (such as PCR) are used to detect and quantify the DNA or RNA of Chlamydia trachomatis.
4. Results are typically available within a few days.

Duration

The sample collection process typically takes about 5-10 minutes. Laboratory processing can take several hours to a few days.

Setting

The sample collection is usually performed in an outpatient clinic, doctor's office, or specialized testing center.

Personnel

• Registered nurse or physician for sample collection.
• Medical laboratory technicians or technologists for sample analysis.

Risks and Complications

• Minor discomfort or mild pain during sample collection.
• Very rare risk of infection or bleeding at the sample collection site.
• False-negative or false-positive results due to sample contamination or improper handling.

Benefits

• Accurate diagnosis of Chlamydia trachomatis infection.
• Quantifies bacterial load to inform treatment.
• Helps prevent complications from untreated infections.
• Results typically available quickly.

Recovery

• No downtime or recovery period needed.
• Patients can resume normal activities immediately after sample collection.
• Follow-up may involve discussing results with your healthcare provider and starting treatment if necessary.

Alternatives

• Culture tests, which may take longer and require specific conditions.
• Antigen detection tests, which may be less sensitive.
• Pros: NAAT is highly sensitive and specific.
• Cons: Slightly higher cost compared to some other tests.

Patient Experience

• Brief discomfort during sample collection, especially if a swab is used.
• Urine sample collection is non-invasive and painless.
• Minimal to no pain after the procedure.
• Results review and discussion with your healthcare provider, including any treatment plans based on findings.